Liver cancer research aims to unlock secrets of immunotherapy response
NCT ID NCT04145141
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study gathers blood, urine, stool, and tissue samples from 132 adults with primary liver cancer who are receiving or have received immunotherapy. Researchers will analyze these samples along with medical records to learn more about how liver cancer develops and responds to treatment. Participants are followed for life by phone or email, but no new treatments are given as part of this study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors design better, more personalized immunotherapies for liver cancer patients.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data and samples but does not test a new therapy directly, so it may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?